· Volume surge · RGC
Regencell Bioscience Holdings Ltd (RGC) volume expands into a sharp weekly selloff
Weekly market data show heavier participation as the healthcare name remains weak across one-, four-, and twelve-week measures.
Regencell Bioscience Holdings Ltd (RGC) ended the latest week at 6.480 USD, with the stock down -46.0% for the week in weekly context over 52 weeks.
The move came with 2,189,302 shares traded, almost three times the 13-week average. Trend state is inactive, while Market Dynamics at -1.46 and Relative Strength at -72.5 point to continued pressure rather than stabilization.